In vivo determination of the profile of benzodiazepine ligands by comparing the inhibition of 3H-Ro 15-1788 binding to the modulation of cGMP levels in mouse cerebellum
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (19) , 3765-3769
- https://doi.org/10.1016/0006-2952(88)90413-3
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: DifferencesLife Sciences, 1985
- Increase of cyclic GMP in cerebellum by methyl-6, 7-dimethoxy-4-ethyl-β-carboline-3-car☐ylate (DMCM)Brain Research, 1983
- GABA‐Benzodiazepine‐Barbiturate Receptor InteractionsJournal of Neurochemistry, 1981
- A synthetic non-benzodiazepine ligand for benzodiazepine receptors: A probe for investigating neuronal substrates of anxietyPharmacology Biochemistry and Behavior, 1979
- and inhibition by zopiclone of benzodiazepine binding to rodent brain receptorsLife Sciences, 1979
- Benzodiazepine Receptor: Demonstration in the Central Nervous SystemScience, 1977
- Benzodiazepine receptors in rat brainNature, 1977
- Evidence for an involvement of GABA in the mediation of the cerebellar cGMP decrease and the anticonvulsant action of diazepamNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975
- Suppression of inhibition in the cerebellar cortex by picrotoxin and bicucullineBrain Research, 1971
- GABA, Bicuculline and Central InhibitionNature, 1970